IFP Advisors’s ReShape Lifesciences Inc. Common Stock RSLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-5
Closed 3904
2018
Q4
$0 Buy
+5
New +$12 ﹤0.01% 4064

IFP Advisors's RSLS Position: Q1 2019 in Review

IFP Advisors sold out of ReShape Lifesciences Inc. Common Stock (RSLS) in Q1 2019, closing a stake of 5 shares.

IFP Advisors first reported a position in RSLS in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 0 funds tracked by Wall St. Rank hold RSLS as of Q1 2019.

  • IFP Advisors reported no remaining ReShape Lifesciences Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • IFP Advisors sold 5 ReShape Lifesciences Inc. Common Stock shares in Q1 2019.
  • IFP Advisors first reported a position in ReShape Lifesciences Inc. Common Stock in Q4 2018 and held it in 1 quarter.
  • IFP Advisors's ReShape Lifesciences Inc. Common Stock position peaked at $0 in Q4 2018.
  • 0 funds tracked by Wall St. Rank held ReShape Lifesciences Inc. Common Stock as of Q1 2019.

Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.